MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences EV - Enterprise Value 2011-2026 | ANIX
Annual EV - Enterprise Value Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 990 K | 1.5 M | 1.39 M | -10 M | 32.5 M | 53 M | 73.8 M | 67.3 M | 28 M | 56.9 M | 27 M | 42.4 M | 53.2 M | 46.4 M | 30.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 73.8 M | -10 M | 33.7 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Bioventus
BVS
|
1.01 B | $ 8.99 | 1.35 % | $ 599 M |  USA |
 |
Brainsway Ltd.
BWAY
|
223 M | $ 13.73 | 0.59 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
665 M | $ 25.9 | 0.27 % | $ 719 M | USA |
 |
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
28.2 B | $ 67.32 | 1.48 % | $ 26.3 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
15.2 B | $ 88.75 | 1.8 % | $ 11.1 B | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 153.71 | 1.14 % | $ 7.62 B | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 17.6 | 1.62 % | $ 938 M | USA |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | $ 103.94 | 0.09 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
502 M | $ 15.43 | 3.21 % | $ 467 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
142 M | $ 16.59 | -4.05 % | $ 2.15 B | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 100.49 | 2.95 % | $ 8.29 B |  Irlanda |
 |
IQVIA Holdings
IQV
|
49.6 B | $ 168.43 | 2.15 % | $ 29 B | USA |
 |
Danaher Corporation
DHR
|
145 B | $ 195.21 | 2.0 % | $ 139 B | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.38 | 1.47 % | $ 414 M | USA |
 |
Illumina
ILMN
|
15.3 B | $ 120.84 | 1.31 % | $ 19.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 198.61 | -0.17 % | $ 22 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
45.8 B | $ 112.75 | 0.82 % | $ 34.3 B | USA |
 |
BioNano Genomics
BNGO
|
35.7 M | $ 1.13 | 1.8 % | $ 1.44 M | USA |
 |
DarioHealth Corp.
DRIO
|
6.61 M | $ 8.75 | 3.92 % | $ 248 M | Israel |
 |
NeoGenomics
NEO
|
1.85 B | $ 8.27 | 0.36 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.27 | 1.76 % | $ 2.01 B | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 80.45 | 2.48 % | $ 5.43 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 455.15 | 0.33 % | $ 13.1 B | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 206.72 | 0.63 % | $ 24.9 B |  Schweiz |
 |
Celcuity
CELC
|
506 M | $ 114.11 | -0.69 % | $ 4.5 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
432 M | $ 17.73 | 1.9 % | $ 397 M | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 47.28 | 5.04 % | $ 2.83 B | USA |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
5.53 B | $ 198.38 | 0.35 % | $ 19.5 B | USA |